Kevin S. Boyle, the former CEO of Kuur Therapeutics, has been named as the new CEO of Ziopharm Oncology. Raffaele Baffa, M.D., Ph.D., Chief Medical…
Kevin S. Boyle, the former CEO of Kuur Therapeutics, has been named as the new CEO of Ziopharm Oncology. Raffaele Baffa, M.D., Ph.D., Chief Medical…